scholarly journals PREVALENCE OF MYOCARDIAL EDEMA WITH T2 MAPPING IN HYPERTROPHIC CARDIOMYOPATHY

2021 ◽  
Vol 77 (18) ◽  
pp. 1303
Author(s):  
Mirza Baig ◽  
Patrycja Galazka ◽  
Omar Dakwar ◽  
Sameh A. Syed ◽  
Rahul Sawlani ◽  
...  
Author(s):  
Andréa Silvestre de Sousa ◽  
Maria Eduarda Derenne ◽  
Alejandro Marcel Hasslocher-Moreno ◽  
Sérgio Salles Xavier ◽  
Ilan Gottlieb

2015 ◽  
Vol 56 (9) ◽  
pp. 1085-1090 ◽  
Author(s):  
Rui Xia ◽  
Xi Lu ◽  
Bing Zhang ◽  
Yuqing Wang ◽  
Jichun Liao ◽  
...  

Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Frederik H Verbrugge ◽  
Endry Willems ◽  
Philippe B Bertrand ◽  
Ellen Gielen ◽  
Wilfried Mullens ◽  
...  

Introduction: Cardiac magnetic resonance (CMR) imaging with quantitative T2-mapping allows identi[[Unable to Display Character: &#64257;]]cation of myocardial edema, improving risk-stratification in acute coronary syndromes and myocarditis. Hypothesis: Global myocardial edema contributes to left ventricular (LV) dysfunction in advanced decompensated heart failure (ADHF). Methods: CMR with quantitative T2-mapping was performed in consecutive ADHF patients (n=17) undergoing right heart catheterization for worsening dyspnea and volume overload. Patients received vasodilators and diuretics to achieve pulmonary capillary wedge pressure (PCWP) ≤18 mmHg and central venous pressure (CVP) ≤10 mmHg, while maintaining mean arterial pressure ≥65 mmHg. After reaching hemodynamic targets, the pulmonary arterial catheter was removed and CMR imaging repeated. Changes in LV T2-values, hemodynamics, and CMR volumetric measurements were compared. Results: Study patients (64±11 years, male 88%, LV ejection fraction 23±8%, ischemic cardiomyopathy 50%) received decongestive treatment during 5±2 days. PCWP and CVP decreased from 25±7 to 17±4 mmHg and 13±6 to 7±3 mmHg, respectively (p<0.001 for both), while cardiac index increased from 2.14±0.60 to 2.58±0.49 L/min/m 2 (p=0.012). LV T2-values dropped consistently from 59.6±4.9 ms to 56.3±5.2 ms after decongestion (p=0.002; Figure). Decreasing LV T2-values correlated well to both decreasing PCWP (r=0.75; p=0.001) and increasing cardiac index (r=0.58; p=0.023). Although LV end-diastolic volume index (142±31 to 135±34 mL/m 2 ; p=0.033) and end-systolic volume index (110±29 to 99±33 mL/m 2 ; p=0.001) both decreased significantly, the extent of these changes were not correlated to changing T2-values (r=0 and 0.11, respectively; p=ns). Conclusions: Global LV myocardial edema is observed in ADHF and reversible with successful decongestive therapy. Relief of myocardial edema strongly correlates with improvements in systolic and diastolic function.


2018 ◽  
Vol 71 (11) ◽  
pp. A724
Author(s):  
Giancarlo Todiere ◽  
Francesco Radico ◽  
Fabiola Cosentino ◽  
Chrysanthos Grigoratos ◽  
Andrea Barison ◽  
...  

Open Heart ◽  
2020 ◽  
Vol 7 (1) ◽  
pp. e001152 ◽  
Author(s):  
Mareike Gastl ◽  
Christiane Gruner ◽  
Karin Labucay ◽  
Alexander Gotschy ◽  
Jochen Von Spiczak ◽  
...  

BackgroundHypertrophic cardiomyopathy (HCM) is associated with an increased risk of adverse cardiac events. Beyond classic risk factors, relative myocardial ischaemia and succeeding myocardial alterations, which can be detected using either contrast agents or parametric mapping in cardiovascular magnetic resonance (CMR) imaging, have shown an impact on outcome in HCM. CMR may help to risk stratify using parametric T2* mapping. Therefore, the aim of the present study was to evaluate the association of T2* values or fibrosis with cardiovascular events in HCM.MethodsThe relationship between T2* with supraventricular, ventricular arrhythmia or heart failure was retrospectively assessed in 91 patients with HCM referred for CMR on a 1.5T MR imaging system. Fibrosis as a reference was added to the model. Patients were subdivided into groups according to T2* value quartiles.Results47 patients experienced an event of ventricular arrhythmia, 25 of atrial fibrillation/flutter and 17 of heart failure. T2*≤28.7 ms yielded no association with ventricular events in the whole HCM cohort. T2* of non-obstructive HCM showed a significant association with ventricular events in univariate analysis, but not in multivariate analysis. For the combined endpoint of arrhythmic events, there was already an association for the whole HCM cohort, but again only in univariate analyses. Fibrosis stayed the strongest predictor in all analyses. There was no association for T2* and fibrosis with heart failure.ConclusionsDecreased T2* values by CMR only provide a small association with arrhythmic events in HCM, especially in non-obstructive HCM. No information is added for heart failure.


Author(s):  
Janelle Yu ◽  
Dominik P Guensch ◽  
Kady Fischer ◽  
Gobinath Nadeshalingam ◽  
Matthias G Friedrich

2012 ◽  
Vol 18 (8) ◽  
pp. S22
Author(s):  
Gina G. Mentzer ◽  
David Verhaert ◽  
Shivraman Giri ◽  
Sitaramesh Emani ◽  
Beth McCarthy ◽  
...  

2015 ◽  
Vol 17 (S1) ◽  
Author(s):  
Enver Tahir ◽  
Martin R Sinn ◽  
Ulf K Radunski ◽  
Dennis Säring ◽  
Christian Stehning ◽  
...  

2015 ◽  
Vol 17 (S1) ◽  
Author(s):  
Hsin-Jung Yang ◽  
Jianing Pang ◽  
Behzad Sharif ◽  
Avinash Kali ◽  
Xiaoming Bi ◽  
...  

2021 ◽  
Vol 8 ◽  
Author(s):  
Karolina Dorniak ◽  
Lorenzo Di Sopra ◽  
Agnieszka Sabisz ◽  
Anna Glinska ◽  
Christopher W. Roy ◽  
...  

Background: T2 mapping is a magnetic resonance imaging technique that can be used to detect myocardial edema and inflammation. However, the focal nature of myocardial inflammation may render conventional 2D approaches suboptimal and make whole-heart isotropic 3D mapping desirable. While self-navigated 3D radial T2 mapping has been demonstrated to work well at a magnetic field strength of 3T, it results in too noisy maps at 1.5T. We therefore implemented a novel respiratory motion-resolved compressed-sensing reconstruction in order to improve the 3D T2 mapping precision and accuracy at 1.5T, and tested this in a heterogeneous patient cohort.Materials and Methods: Nine healthy volunteers and 25 consecutive patients with suspected acute non-ischemic myocardial injury (sarcoidosis, n = 19; systemic sclerosis, n = 2; acute graft rejection, n = 2, and myocarditis, n = 2) were included. The free-breathing T2 maps were acquired as three ECG-triggered T2-prepared 3D radial volumes. A respiratory motion-resolved reconstruction was followed by image registration of the respiratory states and pixel-wise T2 mapping. The resulting 3D maps were compared to routine 2D T2 maps. The T2 values of segments with and without late gadolinium enhancement (LGE) were compared in patients.Results: In the healthy volunteers, the myocardial T2 values obtained with the 2D and 3D techniques were similar (45.8 ± 1.8 vs. 46.8 ± 2.9 ms, respectively; P = 0.33). Conversely, in patients, T2 values did differ between 2D (46.7 ± 3.6 ms) and 3D techniques (50.1 ± 4.2 ms, P = 0.004). Moreover, with the 2D technique, T2 values of the LGE-positive segments were similar to those of the LGE-negative segments (T2LGE−= 46.2 ± 3.7 vs. T2LGE+ = 47.6 ± 4.1 ms; P = 0.49), whereas the 3D technique did show a significant difference (T2LGE− = 49.3 ± 6.7 vs. T2LGE+ = 52.6 ± 8.7 ms, P = 0.006).Conclusion: Respiratory motion-registered 3D radial imaging at 1.5T led to accurate isotropic 3D whole-heart T2 maps, both in the healthy volunteers and in a small patient cohort with suspected non-ischemic myocardial injury. Significantly higher T2 values were found in patients as compared to controls in 3D but not in 2D, suggestive of the technique's potential to increase the sensitivity of CMR at earlier stages of disease. Further study will be needed to demonstrate its accuracy.


Sign in / Sign up

Export Citation Format

Share Document